Lund, 29th June, 2026 – Hamlet Biopharma receives European Regulatory Approval
Preview text: Lund, 29th June, 2026 – Hamlet Biopharma receives European Regulatory Approval
Image not available
No image available for this email.
- Subject
- Lund, 29th June, 2026 – Hamlet Biopharma receives European Regulatory Approval
- Preview text
- Lund, 29th June, 2026 – Hamlet Biopharma receives European Regulatory Approval
- From
- info@
hamletbiopharma.com - Brand
- Hamlet BioPharma
- ESP
- Mailchimp
- Sent
- Mon Jun 29, 2026, 8:29 AM ET
- Size
- 61 KB
- Images
- 8
- Links
- 7, 2 of them buttons
- Subject length
- 78 characters
Against Hamlet BioPharma's usual
Sent in the 8 AM hour, which holds 6% of its emails; 16% arrive in the 4 AM hour. The subject is 78 characters; its average is 47.
Sent just before and after
| Jul 28, 2026 7:11 AM | PRESSRELEASE Lund, July 28th, 2026 | |
| Jul 17, 2026 4:45 AM | Uppdatering inför ordinarie teckningsperiod för teckningsoptioner TO5B | |
| Jul 16, 2026 3:11 PM | Pressrelease – Lund, 16 juli 2026 | |
| Jun 29, 2026 8:29 AM | Lund, 29th June, 2026 – Hamlet Biopharma receives European Regulatory Approval (this email) | |
| Jun 29, 2026 5:14 AM | Pressrelease – Lund, June 29th, 2026 | |
| Jun 29, 2026 5:14 AM | Pressrelease – Lund, 29 juni 2026 | |
| Jun 25, 2026 10:29 AM | PRESS RELEASE Lund, June 25th, 2026 |
More from Hamlet BioPharma
All Hamlet BioPharma emailsBladder cancer treatment with Alpha1H Highlighted in International Scientific Publication
Nov 10, 2026 9:52 AM
Blåscancerbehandling med Alpha1H uppmärksammas i internationell vetenskaplig publikation
Nov 10, 2026 9:49 AM
Nov 9, 2026 5:45 AM
Hamlet BioPharma publicerar årsredovisning 2025/2026
Oct 30, 2026 4:01 AM
PRESS RELEASE Lund, October 28th, 2026
Oct 28, 2026 6:09 AM
